Association of PFN1 Gene Polymorphisms with Bone Mineral Density, Bone Turnover Markers, and Osteoporotic Fractures in Chinese Population

[1]  C. Wang,et al.  PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass , 2021, Pharmacogenomics and Personalized Medicine.

[2]  Baojie Li,et al.  Mutations in Profilin 1 Cause Early‐Onset Paget's Disease of Bone With Giant Cell Tumors , 2021, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  C. Bellan,et al.  Mutation of PFN1 gene in an early onset, polyostotic Paget's-like disease. , 2020, The Journal of clinical endocrinology and metabolism.

[4]  F. Gianfrancesco,et al.  The Loss of Profilin 1 Causes Early Onset Paget's Disease of Bone , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  C. Cooper,et al.  Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis , 2019, Advances in Therapy.

[6]  M. Noda,et al.  Profilin 1 Negatively Regulates Osteoclast Migration in Postnatal Skeletal Growth, Remodeling, and Homeostasis in Mice , 2019, JBMR plus.

[7]  K. Moriyama,et al.  Profilin1 is expressed in osteocytes and regulates cell shape and migration , 2018, Journal of cellular physiology.

[8]  A. Davis,et al.  Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair , 2017, Nature Communications.

[9]  R. Eastell,et al.  Use of bone turnover markers in postmenopausal osteoporosis. , 2017, The lancet. Diabetes & endocrinology.

[10]  C. Cooper,et al.  The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide. , 2017, Bone.

[11]  S. Manna,et al.  Profilin-PTEN interaction suppresses NF-κB activation via inhibition of IKK phosphorylation. , 2016, The Biochemical journal.

[12]  G. Braus,et al.  CHK2–BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly , 2016, Proceedings of the National Academy of Sciences.

[13]  J. Cauley,et al.  Degree of Trauma Differs for Major Osteoporotic Fracture Events in Older Men Versus Older Women , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  Marco Y. Hein,et al.  A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances , 2015, Cell.

[15]  J. Condeelis,et al.  Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis , 2014, Oncogene.

[16]  Rui Huang,et al.  PFN1 mutations are rare in Han Chinese populations with amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.

[17]  E. Hohenester,et al.  Laminins in basement membrane assembly , 2013, Cell adhesion & migration.

[18]  S. Sen,et al.  Epidemiology of falls and osteoporotic fractures: a systematic review , 2012, ClinicoEconomics and outcomes research : CEOR.

[19]  Zhenlin Zhang,et al.  Susceptibility genes for osteoporotic fracture in postmenopausal chinese women , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  D. D'cruz,et al.  Osteoporosis—a risk factor for cardiovascular disease? , 2012, Nature Reviews Rheumatology.

[21]  S. C. Chafe,et al.  Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis , 2012, Nature.

[22]  A. Vlahou,et al.  Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness* , 2011, Molecular & Cellular Proteomics.

[23]  Lin Zhao,et al.  Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. , 2010, The Journal of clinical endocrinology and metabolism.

[24]  Hui Shen,et al.  Choice of study phenotype in osteoporosis genetic research , 2009, Journal of Bone and Mineral Metabolism.

[25]  Kari Stefansson,et al.  Multiple genetic loci for bone mineral density and fractures. , 2008, The New England journal of medicine.

[26]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[27]  Jacques P. Brown,et al.  The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women , 2007, Osteoporosis International.

[28]  Troels Z. Kristiansen,et al.  Biomarker Discovery from Pancreatic Cancer Secretome Using a Differential Proteomic Approach*S , 2006, Molecular & Cellular Proteomics.

[29]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[30]  W. Witke.  The role of profilin complexes in cell motility and other cellular processes. , 2004, Trends in cell biology.

[31]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[32]  R. Recker,et al.  Relevance of the genes for bone mass variation to susceptibility to osteoporotic fractures and its implications to gene search for complex human diseases , 2002, Genetic epidemiology.

[33]  M. Mann,et al.  In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly , 1998, The EMBO journal.

[34]  S. Cummings,et al.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis , 1996 .

[35]  M. Nevitt,et al.  Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  S. Cummings,et al.  Postmenopausal osteoporosis , 2016, Nature Reviews Disease Primers.